News

View news about our firm and developments in our cases.

Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Questar Corporation
February 05, 2016

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of  Questar Corporation (“Questar” or “Company”) (NYSE: STR) concerning the Company’s proposed acquisition by Dominion Resources Inc. (NYSE: D). 

Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Media General, Inc.
February 02, 2016

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Media General, Inc.(“Media General” or “Company”) (NYSE: MEG) concerning the Company’s proposed acquisition by Nexstar Broadcasting Group Inc. (NYSE: NXST).

 

Finkelstein Thompson LLP Investigates Allegations Against EOS Lip Balm
January 28, 2016

Finkelstein Thompson is investigating claims that the popular EOS lip balm allegedly mislead consumers by advertising its signature lip balm as natural and healthful. However, several customers have displayed adverse symptoms  which dermatologists have found, might be attributable to use of EOS lip balm.

Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of FirstMerit Corporation
January 27, 2016

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of FirstMerit Corporation(“FirstMerit” or “Company”) (Nasdaq GS: FMER) concerning the Company’s proposed acquisition by Huntington Bancshares Inc. (Nasdaq GS: HBAN). 

Finkelstein Thompson LLP Investigates VTech Data Breach
January 27, 2016

Finkelstein Thompson is conducting an investigation into the recent hacking of childrens’ toys made by VTech. 

Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Northern Tier Energy LP
January 07, 2016

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Northern Tier Energy LP (“Northern Tier Energy” or “Company”) (NYSE: NTI), concerning the Company’s proposed acquisition by Western Refining, Inc. (“Western Refining”) (NYSE: WNR).

Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Jarden Corp. (NYSE:JAH)
December 15, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Jarden Corp. (“Company” or “Jarden”) (NYSE: JAH) concerning the Company’s proposed acquisition by Newell Rubbermaid Inc. (NYSE: NWL). 

Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of American Residential Properties
December 10, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of American Residential Properties Inc. (“ARPI” or “Company”)  (NYSE: ARPI), concerning the Company’s proposed acquisition by American Homes 4 Rent (NYSE: AMH). Under the terms of the proposal, ARPI shareholders will receive $19.80 for each share of ARPI’s common stock owned. At least one analyst has set a high target price of $23.00 for ARPI shares. The entire transaction is valued at approximately $1.34 billion.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Mattson Technology, Inc.
December 07, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Mattson Technology, Inc. (“Mattson” or “Company”) (MTSN: NasdaqGS),  concerning the Company’s proposed acquisition by Beijing E-Town Dragon Semiconductor Industry Investment Center (“E-Dragon”). 

Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Starwood Hotels & Resorts WW Inc.
November 17, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Starwood Hotels & Resorts Worldwide, Inc. (“Starwood” or “Company”) (NYSE: HOT), concerning the Company’s proposed acquisition by Marriott International, Inc.(“Marriott”) (NasdaqGS: MAR). 
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Plum Creek Timber Co. Inc.
November 13, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Plum Creek Timber Co. Inc. (“Plum Creek” or “Company”) (NYSE: PCL), concerning the Company’s proposed acquisition by Weyerhaeuser Company (“Weyerhaeuser”) (NYSE: WY). 
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Fidelity & Guaranty Life Common
November 13, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Fidelity & Guaranty Life Common (“Fidelity” or “Company”) (NYSE: FGL), concerning the Company’s proposed acquisition by Anbang Insurance Group Co., Ltd.(“Anbang”). 
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of RealD Inc.
November 10, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of RealD Inc. (“RealD” or “Company”) (NYSE: RLD), concerning the Company’s proposed acquisition by Rizvi Traverse Management, LLC (“Rizvi”). 
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of MedAssets, Inc.
November 09, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of MedAssets, Inc. (“MedAssets” or “Company”) (NasdaqGS: MDAS), concerning the Company’s proposed acquisition by Pamplona Capital Management (“Pamplona Capital”). 
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Astoria Financial Corporation
November 09, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Astoria Financial Corporation (“Astoria Financial” or “Company”) (NYSE: AF), concerning the Company’s proposed acquisition by New York Community Bancorp Inc. (“NYCB”) (NYSE: NYCB). 
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of HomeAway Inc.
November 09, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of HomeAway Inc. (“HomeAway” or “Company”) (NasdaqGS: AWAY), concerning the Company’s proposed acquisition by Expedia Inc. (“Expedia”) (NasdaqGS: EXPE). 
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of ZS Pharma, Inc.
November 09, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of ZS Pharma, Inc. (“ZS Pharma” or “Company”) (NasdaqGM: ZSPH), concerning the Company’s proposed acquisition by AstraZeneca PLC (“AstraZeneca”) (NYSE: AZN). 
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Dyax Corp.
November 09, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Dyax Corp. (“Dyax” or “Company”) (NasdaqGM: DYAX), concerning the Company’s proposed acquisition by Shire PLC (“Shire”) (NASDAQ: SHPG). 
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Constant Contact, Inc.
November 02, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Constant Contact, Inc. (“Constant Contact” or “Company”) (NasdaqGS: CTCT), concerning the Company’s proposed acquisition by Endurance International Group Holdings, Inc. (“Endurance”)  (NasdaqGS: EIGI). 
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Rite Aid Corporation
November 02, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Rite Aid Corporation (“Rite Aid” or “Company”) (NYSE: RAD), concerning the Company’s proposed acquisition by Walgreens Boots Alliance, Inc. (“Walgreens”) (NASDAQ: WBA). 
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Diamond Foods, Inc.
November 02, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Diamond Foods, Inc. (“Diamond Foods” or “Company”) (NasdaqGS: DMND), concerning the Company’s proposed acquisition by Snyder’s-Lance, Inc. (“Snyder’s”) (NasdaqGS: LNCE). 
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of First Niagara Financial Group Inc
October 30, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of First Niagara Financial Group Inc.(“First Niagara” or “Company”) (NASDAQ: FNFG), concerning the Company’s proposed acquisition by KeyCorp (NYSE: KEY). 
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of VBI Vaccines Inc.
October 29, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of VBI Vaccines Inc. (“VBI” or “Company”) (NYSE: VBIV), concerning the Company’s proposed acquisition by SciVac Therapeutics Inc. (“SciVac”). 
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Piedmont Natural Gas Co. Inc.
October 28, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Piedmont Natural Gas Co. Inc. (“Piedmont” or “Company”) (NYSE: PNY), concerning the Company’s proposed acquisition by Duke Energy Corporation (“Duke”) (NYSE: DUK).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of KLA-Tencor Corp.
October 23, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of KLA-Tencor Corp.  (“KLA-Tencor” or “Company”) (NasdaqGS: KLAC), concerning the Company’s proposed acquisition by Lam Research Corp. (“Lam Research”) (NasdaqGS: LRCX).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of SanDisk Corp.
October 23, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of SanDisk Corp. (“SanDisk” or “Company”) (NasdaqGS: SNDK), concerning the Company’s proposed acquisition by Western Digital (Nasdaq: WDC).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of NewBridge Bancorp
October 23, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of NewBridge Bancorp (“NewBridge” or “Company”), concerning the Company’s proposed acquisition by Yadkin Financial Corporation (“Yadkin”).

Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of EMC Corporation
October 16, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of EMC Corporation (“EMC” or “Company”), concerning the Company’s proposed acquisition by Dell, Inc. (“DELL”)

Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Wausau Paper Corp.
October 15, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Wausau Paper Corp., concerning the Company’s proposed acquisition by SCA Americas Inc. 

Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of BioMed Realty Trust, Inc.
October 08, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of BioMed Realty Trust, Inc. (“BioMed” or the “Company”) (NYSE: BMR), concerning the Company’s proposed acquisition by Blackstone Real Estate Partners VIII (“Blackstone”)
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of PMC-Sierra, Inc.
October 08, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of PMC-Sierra, Inc. (“PMC” or the “Company”) (NASDAQ GS: PMCS), concerning the Company’s proposed acquisition by (“Skyworks”) (NASDAQ GS: SWKS)
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of The Williams Companies
October 02, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of The Williams Companies (“Williams” or the “Company”) (NYSE: WMB), concerning the Company’s proposed acquisition by Energy Transfer Equity, L.P. (“ETE”) (NYSE: ETE).
Finkelstein Thompson LLP Investigates Excellus Blue Cross Blue Shield Data Breach
September 25, 2015

Finkelstein Thompson LLP is investigating a potential class action lawsuit on behalf of consumers affected by the recent Excellus Blue Cross Blue Shield data breach.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Atmel Corporation
September 24, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Atmel Corporation (“Atmel” or the “Company”) (NASDAQ GS: ATML), concerning the Company’s proposed acquisition by Dialog Semiconductor Plc (“Dialog”).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Solera Holdings, Inc.
September 17, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Solera Holdings, Inc. (“Solera” or the “Company”) (NYSE: SLH), concerning the Company’s proposed acquisition by an affiliate of Vista Equity Partners (“Vista”).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Cameron International Corporation
August 27, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Cameron International Corporation (“Cameron” or the “Company”) (NYSE: CAM), concerning the Company’s proposed acquisition by Schlumberger Limited (“Schlumberger”) (NYSE: SLB).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of AGL Resources Inc.
August 25, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of AGL Resources Inc. (“AGL” or the “Company”) (NYSE: GAS), concerning the Company’s proposed acquisition by The Southern Company (“Southern Company”) (NYSE: SO).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of National Penn Bancshares, Inc.
August 18, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of National Penn Bancshares, Inc. (“National Penn” or the “Company”) (NASDAQ GS: NPBC), concerning the Company’s proposed acquisition by BB&T Corporation (“BB&T”) (NYSE: BBT).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of NTELOS Holdings Corp.
August 12, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of NTELOS Holdings Corp. (“NTELOS” or the “Company”) (NASDAQ GS: NTLS), concerning the Company’s proposed acquisition by Shenandoah Telecommunications Company (“Shentel”) (NASDAQ GS: SHEN).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Precision Castparts Corp.
August 11, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Precision Castparts Corp. (“PCC” or the “Company”) (NYSE: PCP), concerning the Company’s proposed acquisition by Berkshire Hathaway Inc. (“Berkshire Hathaway”) (NYSE: BRKA).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Merge Healthcare Incorporated
August 07, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Merge Healthcare Incorporated (“Merge Healthcare” or the “Company”) (NASDAQ GS: MRGE), concerning the Company’s proposed acquisition by International Business Machines Corporation (“IBM”) (NYSE: IBM).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of IPC Healthcare, Inc.
August 06, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of IPC Healthcare, Inc. (“IPC” or the “Company”) (NASDAQ GS: IPCM), concerning the Company’s proposed acquisition by Team Health Holdings, Inc. (“Team Health”) (NYSE: TMH).
Finkelstein Thompson LLP Investigates the Honest Company SPF 30 Sunscreen
August 03, 2015

Finkelstein Thompson LLP is investigating consumer complaints about Jessica Alba’s Honest Company SPF 30 Sunscreen.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Cytec Industries Inc.
July 29, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Cytec Industries Inc. (“Cytec” or the “Company”) (NYSE: CYT), concerning the Company’s proposed acquisition by Solvay SA.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Thoratec Corporation
July 29, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Thoratec Corporation (“Thoratec” or the “Company”) (NASDAQ GS: THOR), concerning the Company’s proposed acquisition by St. Jude Medical, Inc. (“St. Jude Medical”) (NYSE: STJ).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Magnetek, Inc.
July 28, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Magnetek, Inc. (“Magnetek” or the “Company”) (NASDAQ:MAG), concerning the Company’s proposed acquisition by Columbus McKinnon Corporation.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Cigna Corp.
July 27, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Cigna Corp. (“Cigna” or the “Company”) (NYSE:CI), concerning the Company’s proposed acquisition by Anthem Inc.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Vivint Solar, Inc.
July 21, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Vivint Solar, Inc. (“Vivint” or the “Company”) (NYSE:VSLR), concerning the Company’s proposed acquisition by SunEdison and TerraForm.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Receptos, Inc.
July 17, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Receptos, Inc. (“Receptos” or the “Company”) (NASDAQ: RCPT), concerning the Company’s proposed acquisition by Celgene Corporation.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of MarkWest Energy Partners
July 14, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of MarkWest Energy Partners (“MarkWest” or the “Company”) (NYSE:MWE), concerning the Company’s proposed acquisition by MPLX LP.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Humana Inc.
July 06, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Humana Inc. (“Humana” or the “Company”) (NYSE:HUM), concerning the Company’s proposed acquisition by Aetna Inc.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Health Net Inc.
July 06, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Health Net Inc. (“Health Net” or the “Company”) (NYSE:HNT), concerning the Company’s proposed acquisition by Centene Corp.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of The Chubb Corporation
July 06, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of The Chubb Corporation (“Chubb” or the “Company”) (NYSE:CB), concerning the Company’s proposed acquisition by ACE Ltd.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Towers Watson & Co.
June 30, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Towers Watson & Co. (“TW” or the “Company”) (NASDAQ: TW), concerning the Company’s proposed acquisition by Willis Group Holdings PLC.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Home Properties, Inc.
June 24, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Home Properties, Inc. (“Home Properties” or the “Company”) (NYSE: HME), concerning the Company’s proposed acquisition by Lone Star Funds.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Martha Stewart Living Omnimedia
June 22, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Martha Stewart Living Omnimedia Inc. (“Martha Stewart Living” or the “Company”) (NYSE: MSO), concerning the Company’s proposed acquisition by Sequential Brands Group, Inc.
Finkelstein Thompson LLP Investigates Nvidia Corp.
June 22, 2015

Finkelstein Thompson LLP is investigating allegations that Nvidia Corp. overstated the processing capabilities of their GTX 970 computer graphics chip.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of KYTHERA Biopharmaceuticals, Inc.
June 18, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of KYTHERA Biopharmaceuticals, Inc. (“Kythera” or the “Company”) (NasdaqGS: KYTH), concerning the Company’s proposed acquisition by Allergan plc.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Dealertrack Technologies, Inc.
June 17, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Dealertrack Technologies, Inc. (“Dealertrack” or the “Company”) (NasdaqGS:TRAK), concerning the Company’s proposed acquisition by Cox Automotive, Inc.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Bio-Reference Laboratories, Inc.
June 09, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Bio-Reference Laboratories, Inc. (“BRLI” or the “Company”) (NASDAQ GS: BRLI), concerning the Company’s proposed acquisition by OPKO Health, Inc. (“OPKO”) (NYSE: OPK).
Finkelstein Thompson LLP Investigates FitBit, Inc.
June 05, 2015

Finkelstein Thompson LLP is investigating allegations that Fitbit’s activity monitors have manufacturing defects that cause skin irritation.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Altera Corporation
June 02, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Altera Corporation (“Altera” or the “Company”) (NASDAQ GS: ALTR), concerning the Company’s proposed acquisition by Intel Corporation (“Intel”) (NASDAQ GS: INTC).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Broadcom Corporation
May 29, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Broadcom Corporation (“Broadcom” or the “Company”) (NASDAQ GS: BRCM), concerning the Company’s proposed acquisition by Avago Technologies Limited (“Avago”) (NASDAQ GS: AVGO).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Rally Software Development Corp.
May 29, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Rally Software Development Corp. (NYSE: RALY), concerning the Company’s proposed acquisition by CA, Inc. (“CA”) (NASDAQ GS: CA).
Finkelstein Thompson LLP Investigates Etsy, Inc.
May 27, 2015

Finkelstein Thompson LLP is investigating securities claims on behalf of investors of Etsy, Inc. (NASDAQ GS: ETSY) resulting from a complaint alleging that Etsy may have issued materially misleading business information to the investing public.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Omnicare, Inc.
May 22, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Omnicare, Inc. (“Omnicare” or the “Company”) (NYSE: OCR), concerning the Company’s proposed acquisition by CVS Health Corporation.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of ANN INC.
May 19, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of ANN INC. (NYSE: ANN), concerning the Company’s proposed acquisition by Ascena Retail Group, Inc. (NASDAQ GS: ASNA).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of AOL Inc.
May 13, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of AOL Inc. (NYSE: AOL), concerning the Company’s proposed acquisition by Verizon Communications Inc. (NYSE: VZ).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Pall Corporation
May 13, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Pall Corporation (NYSE: PLL), concerning the Company’s proposed acquisition by Danaher Corporation (NYSE: DHR).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Quality Distribution, Inc.
May 12, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Quality Distribution, Inc. (Nasdaq: QLTY), concerning the Company’s proposed acquisition by Apax Partners (“Apax”).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Micrel, Incorporated
May 12, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Micrel, Incorporated (NASDAQ GS: MCRL), concerning the Company’s proposed acquisition by Microchip Technology Incorporated (NASDAQ GS: MCHP).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Synageva BioPharma, Inc.
May 12, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Synageva BioPharma, Inc. (Nasdaq: GEVA), concerning the Company’s proposed acquisition by Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Borderfree, Inc.
May 07, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Borderfree, Inc. (NASDAQ GS: BRDR), concerning the Company’s proposed acquisition by Pitney Bowes Inc. (NYSE: PBI).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Cyan, Inc.
May 05, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Cyan, Inc. (NYSE: CYNI), concerning the Company’s proposed acquisition by Ciena Corporation (NYSE: CIEN). 
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of iGate Corp.
April 29, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of iGate Corp. (Nasdaq: IGTE), concerning the Company’s proposed acquisition by Cap Gemini S.A. (PAR: CAP.PA).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Associated Estates Realty Corp.
April 27, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Associated Estates Realty Corporation (NYSE: AEC), concerning the Company’s proposed acquisition by a real estate fund managed by Brookfield Asset Management (“Brookfield”).
Finkelstein Thompson LLP Investigates Trader Joe's Co.
April 15, 2015

Finkelstein Thompson LLP is investigating allegations that grocery chain Trader Joe's violated state and federal law when the company restructured its workforce in March and April of 2014.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Excel Trust, Inc.
April 14, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Excel Trust, Inc. (“Excel” or the “Company”) (NYSE: EXL), concerning the Company’s proposed acquisition by Blackstone Property Partners L.P. (“Blackstone”).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Zep Inc.
April 09, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Zep Inc. (“Zep” or the “Company”) (NYSE: ZEP), concerning the Company’s proposed acquisition by New Mountain Capital, L.L.C. (“New Mountain”).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Informatica Corporation
April 08, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Informatica Corporation (NASDAQ GS: INFA), concerning the Company’s proposed acquisition by a company controlled by the Permira funds and Canada Pension Plan Investment Board (collectively, the “Consortium”).
Finkelstein Thompson LLP Investigates Honey Maid Graham Crackers
April 07, 2015

Finkelstein Thompson LLP is investigating reports that the Honey Maid Graham Crackers packaging contains a strong chemical odor.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Cellular Dynamics International
April 07, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Cellular Dynamics International, Inc. (NASDAQ GM: ICEL), concerning the Company’s proposed acquisition by FUJIFILM Holdings Corporation (“Fujifilm”).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Auspex Pharmaceuticals, Inc.
April 07, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Auspex Pharmaceuticals, Inc. (NASDAQ GM: ASPX), concerning the Company’s proposed acquisition by Teva Pharmaceuticals Industries Ltd. (NYSE: TEVA).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Norcraft Companies, Inc.
April 07, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Norcraft Companies, Inc. (NYSE: NCFT), concerning the Company’s proposed acquisition by Fortune Brands Home & Security, Inc. (NYSE: FBHS).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Hyperion Therapeutics, Inc.
April 07, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Hyperion Therapeutics, Inc. (NASDAQ GS: HPTX), concerning the Company’s proposed acquisition by Horizon Pharma plc (NASDAQ GS: HZNP).
Finkelstein Thompson LLP Investigates Mucinex™
March 25, 2015

Finkelstein Thompson LLP is investigating possible unfair trade practices on behalf of purchasers of Mucinex (extended-release guaifenesin) sold over-the-counter.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Vitesse Semiconductor Corp.
March 20, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Vitesse Semiconductor Corp. (NasdaqGM: VTSS), concerning the Company’s proposed acquisition by Microsemi Corp. (NasdaqGS: MSCC).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Life Time Fitness, Inc.
March 17, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Life Time Fitness, Inc. (NYSE: LTM), concerning the Company’s proposed acquisition by Leonard Green & Partners and TPG.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Integrated Silicon Solution, Inc.
March 16, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Integrated Silicon Solution, Inc. (NASDAQ GS: ISSI), concerning the Company’s proposed acquisition by Summitview Capital.
Finkelstein Thompson LLP Investigates Kohl’s Credit Card
March 11, 2015

Finkelstein Thompson LLP is investigating Kohl’s Corporation Inc. over alleged deceptive tactics in credit card charges.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of The Macerich Company
March 10, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of The Macerich Company (NYSE: MAC), concerning the Company’s proposed acquisition by Simon Property Group, Inc. (NYSE: SPG). 
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Pharmacyclics, Inc.
March 09, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Pharmacyclics, Inc. (NASDAQ GS: PCYC), concerning the Company’s proposed acquisition by AbbVie Inc. (NYSE: ABBV).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Aruba Networks
March 04, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Aruba Networks (NASDAQ: ARUN), concerning the Company’s proposed acquisition by Hewlett-Packard (NYSE: HPQ).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Emulex Corporation
February 27, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Emulex Corporation (NYSE: ELX), concerning the Company’s proposed acquisition by Avago Technologies Limited (NASDAQ GS: AVGO).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Polypore International, Inc.
February 24, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Polypore International, Inc. (NYSE: PPO), concerning the Company’s proposed acquisition by Asahi Kasei Corporation (“Asahi Kasei”).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Salix Pharmaceuticals, Ltd.
February 24, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Salix Pharmaceuticals, Ltd. (NASDAQ GS: SLXP), concerning the Company’s proposed acquisition by Valeant Pharmaceuticals International, Inc. (NYSE: VRX).
Finkelstein Thompson LLP Investigates Lenovo
February 20, 2015

Finkelstein Thompson LLP is investigating allegations that the computer manufacturing company, Lenovo, has been installing adware onto new consumer PCs since at least mid-2014. 

Finkelstein Thompson LLP Investigates Hyundai Motor America
February 19, 2015

Finkelstein Thompson LLP is investigating allegations that Hyundai has marketed it’s Blue Link Telematics System as a standard feature then notifying owners years later after the purchase of the vehicle that the feature would be permanently disabled unless a fee is paid to renew the subscription.
Finkelstein Thompson LLP Investigates Nestlé Purina's Beneful Dog Food
February 19, 2015

Finkelstein Thompson LLP is investigating allegations that Nestlé Purina's Beneful Dog Food has killed or extremely sickened thousands of dogs.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Orbitz Worldwide, Inc.
February 13, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Orbitz Worldwide, Inc. (NYSE: OWW), concerning the Company's proposed acquisition by Expedia, Inc. (NASDAQ GS: EXPE).